Transaction · 0001437749-26-029228

Anderson Raymond

Anderson Raymond, DIR, reported an open-market or private sale at Monopar Therapeutics involving 1802.000000 shares for an estimated $203716.10. Reported holdings after the transaction were 5373.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
MNPRMonopar Therapeutics
Trade date
Aug 25, 2026
Filing date
Aug 28, 2026
View on SEC Insider profile
Estimated value-$203kShares × reported price
Shares traded1.80k$113.05 per share
Holdings after5.37kDirect
% of reported position traded25.11%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 7,175 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
amended filingThis transaction comes from an amended Form 4 filing.

MNPR price since this filing

Daily closing prices, with the filing date and available return windows
MNPR · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -1.8%1w ago +6.4%1d ago -0.5%
Returns since7d +5.1%30d -23.8%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001437749-26-029228
Common Stock
Transaction date
Aug 25, 2026
Filed Aug 28, 2026, 11:41 PM · 3d delay
Shares
1,802 sh
$113.05 per share
Estimated value
-$203k
Computed from shares × price
Holdings after
5,373 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Amended Filing Direct Ownership Large Holdings Reduction Large Sale Repeat Seller 10b5-1 Detected
Filing-only score

-10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
  • amended_filing-6 points

    is_amendment = true

    Amended filing: the original transaction may have been restated.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 26, 2026.

  2. F2

    On September 18, 2017, the reporting person was granted stock options to purchase up to 4,205 shares of common stock. The options vest 6/42nds at the six-month anniversary of grant date and 1/42nd per…

  3. F3

    On August 9, 2018, the reporting person was granted stock options to purchase up to 5,220 shares of common stock. The options vest 20% on January 1, 2019, 20% on April 1, 2019, 20% on July 1, 2019, 20…

  4. F4

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.51 to $110.43, inclusive. The reporting person undertakes to pro…

  5. F5

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.56 to $111.41, inclusive. The reporting person undertakes to pro…

  6. F6

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.84 to $113.11, inclusive. The reporting person undertakes to pro…

Amended filing · 0001437749-26-029228
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

MNPR